Torley Helen
Reporting owner on Forms 3, 4 and 5, CIK 1528185.
Torley Helen reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| HALO · HALOZYME THERAPEUTICS, INC.CIK 1159036 | director, officer (PRESIDENT AND CEO) | 1 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-08 | M exercised | +20,000 | $18.41 | 787,780 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-08 | S sold | -4,810 | $108.179 | 782,970 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-08 | S sold | -3,090 | $108.908 | 779,880 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-08 | S sold | -11,900 | $109.995 | 767,980 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-08 | S sold | -200 | $110.51 | 767,780 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Option to Purchase Common Stock, derivative | 2026-10-08 | M exercised | -20,000 | $18.41 | 21,552 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-07 | M exercised | +20,000 | $18.41 | 787,780 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-07 | S sold | -8,600 | $111.031 | 779,180 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-07 | S sold | -10,300 | $111.839 | 768,880 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-07 | S sold | -900 | $112.78 | 767,980 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-07 | S sold | -200 | $113.693 | 767,780 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Option to Purchase Common Stock, derivative | 2026-10-07 | M exercised | -20,000 | $18.41 | 41,552 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-06 | M exercised | +20,000 | $18.41 | 787,780 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-06 | S sold | -2,300 | $107.902 | 785,480 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-06 | S sold | -6,000 | $109.334 | 779,480 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-06 | S sold | -9,920 | $109.891 | 769,560 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Common Stock | 2026-10-06 | S sold | -1,780 | $110.812 | 767,780 | Form 4 |
| HALO · HALOZYME THERAPEUTICS, INC.Option to Purchase Common Stock, derivative | 2026-10-06 | M exercised | -20,000 | $18.41 | 61,552 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001159036-26-000140 | HALOZYME THERAPEUTICS, INC. | 2026-10-08 |